PRIMA·DERM was founded in 2008 by a world reference chemist, Dr. García Antón, recognized for developing the Argireline® and SNAP®, which are better known for being the first anti-wrinkle peptides to express a botox-like effect. For more than 15 years we have continued to share a deep commitment for skincare, offering dermocosmetic products based on science, and driven by innovation.
PRIMA·DERM is a pioneer in developing and controlling every process involved in the creation of our formulas. We are able to achieve this goal through research and analysis, as well as for understanding the needs of our patients, skin professionals and distributors.
From creating our own active ingredients that include peptides, growth factors and biotechnological extracts, to the development of proprietary novelty delivery systems in our in-house laboratory; allows us to introduce the highest concentrations of active ingredients and thus guaranteeing efficacy and results.
Singuladerm emerges as the main brand of Prima·Derm laboratories; the first advanced skincare brand expert in molecular and preventive cosmetics that transfers pharmaceutical science to dermocosmetics.
-
Industry
-
Cosmetics
-
Company size
-
51-200 employees
-
Headquarters
-
Gavà, Barcelona
-
Type
-
Privately Held
-
Founded
-
2008
-
Specialties
-
Molecular cosmetics, Peptides, Biotechnological Extracts, Delivery Systems, Growth Factors, Computational Science, Leaders in peptides, Skincare, Dermocosmetics, and Cosmetics
